Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biolife Solutions (NQ: BLFS )

34.60 USD -0.39 (-1.11%)
Streaming Delayed Price Updated: 2:31 PM EST, Dec 2, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 164,130
Open 34.95
Bid (Size) 34.49 (1)
Ask (Size) 34.70 (2)
Prev. Close 34.99
Today's Range 34.11 - 34.95
52wk Range 7.370 - 37.15
Shares Outstanding 15,104,743
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
iVexSol Announces Series A Funding
Technology targets critical shortage of viral vectors for the rapidly expanding field of cell and gene therapeutics 
From GlobeNewswire News Releases
BioLife Solutions & Casdin Capital Innovation Accelerator Announce New Investments in Cell & Gene Therapy Bioproduction Tools
Follow-on investment in iVexSol; Viral Vector Manufacturing Platform 
From PR Newswire

Performance

YTD
+110.98%
+110.98%
1 Month
+17.05%
+17.05%
3 Month
+52.62%
+52.62%
6 Month
+115.44%
+115.44%
1 Year
+119.40%
+119.40%

More News

Read More
BioLife Solutions Ranked 403rd Fastest Growing Company in North America on Deloitte's 2020 Technology Fast 500™
From PR Newswire
BioLife Solutions Announces Third Quarter 2020 Financial Results
From PR Newswire
BioLife Solutions to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020
From PR Newswire
BioLife Solutions SciSafe Division Secures $2.7 Million Cold Chain and Storage Contract for COVID-19 Vaccines
From PR Newswire
Austin Lieberman: Why Investors Shouldn't Be Afraid Of Expensive Stocks
From Investor's Business Daily
The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit
Tags LUNG ZLAB VCYT
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Tags IDT INSP NTLA
From Benzinga
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies
Tags TCON TCRR CALT
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Tags NSC RGT WCN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.